Global and United States Human Insulin Delivery System Market Insights, Forecast to 2031

Report ID: 1024953 | Published Date: Oct 2024 | No. of Page: 145 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Insulin Delivery System Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Insulin Delivery System Market Size Growth Rate by Type
        1.2.2 Automatic
        1.2.3 Manual
    1.3 Market by Application
        1.3.1 Global Human Insulin Delivery System Market Size Growth Rate by Application
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Homecare
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Human Insulin Delivery System Market Size, Estimates and Forecasts
        2.1.1 Global Human Insulin Delivery System Revenue 2016-2027
        2.1.2 Global Human Insulin Delivery System Sales 2016-2027
    2.2 Global Human Insulin Delivery System, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Human Insulin Delivery System Historical Market Size by Region (2016-2021)
        2.3.1 Global Human Insulin Delivery System Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Human Insulin Delivery System Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Human Insulin Delivery System Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Human Insulin Delivery System Sales Forecast by Region (2022-2027)
        2.4.2 Global Human Insulin Delivery System Revenue Forecast by Region (2022-2027)

3 Global Human Insulin Delivery System Competitor Landscape by Players
    3.1 Global Top Human Insulin Delivery System Manufacturers by Sales
        3.1.1 Global Human Insulin Delivery System Sales by Manufacturer (2016-2021)
        3.1.2 Global Human Insulin Delivery System Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Human Insulin Delivery System Manufacturers by Revenue
        3.2.1 Key Human Insulin Delivery System Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Human Insulin Delivery System Revenue by Manufacturers (2016-2021)
        3.2.3 Global Human Insulin Delivery System Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Human Insulin Delivery System Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Human Insulin Delivery System Revenue in 2020
        3.2.6 Global Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Human Insulin Delivery System Price by Manufacturers
    3.4 Global Human Insulin Delivery System Manufacturing Base Distribution, Product Types
        3.4.1 Human Insulin Delivery System Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Human Insulin Delivery System Product Type
        3.4.3 Date of International Manufacturers Enter into Human Insulin Delivery System Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Human Insulin Delivery System Market Size by Type (2016-2021)
        4.1.1 Global Human Insulin Delivery System Sales by Type (2016-2021)
        4.1.2 Global Human Insulin Delivery System Revenue by Type (2016-2021)
        4.1.3 Human Insulin Delivery System Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Human Insulin Delivery System Market Size Forecast by Type (2022-2027)
        4.2.1 Global Human Insulin Delivery System Sales Forecast by Type (2022-2027)
        4.2.2 Global Human Insulin Delivery System Revenue Forecast by Type (2022-2027)
        4.2.3 Human Insulin Delivery System Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Human Insulin Delivery System Market Size by Application (2016-2021)
        5.1.1 Global Human Insulin Delivery System Sales by Application (2016-2021)
        5.1.2 Global Human Insulin Delivery System Revenue by Application (2016-2021)
        5.1.3 Human Insulin Delivery System Price by Application (2016-2021)
    5.2 Human Insulin Delivery System Market Size Forecast by Application (2022-2027)
        5.2.1 Global Human Insulin Delivery System Sales Forecast by Application (2022-2027)
        5.2.2 Global Human Insulin Delivery System Revenue Forecast by Application (2022-2027)
        5.2.3 Global Human Insulin Delivery System Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Human Insulin Delivery System Market Size YoY Growth 2016-2027
        6.1.1 United States Human Insulin Delivery System Sales YoY Growth 2016-2027
        6.1.2 United States Human Insulin Delivery System Revenue YoY Growth 2016-2027
        6.1.3 United States Human Insulin Delivery System Market Share in Global Market 2016-2027
    6.2 United States Human Insulin Delivery System Market Size by Players (International and Local Players)
        6.2.1 United States Top Human Insulin Delivery System Players by Sales (2016-2021)
        6.2.2 United States Top Human Insulin Delivery System Players by Revenue (2016-2021)
    6.3 United States Human Insulin Delivery System Historic Market Review by Type (2016-2021)
        6.3.1 United States Human Insulin Delivery System Sales Market Share by Type (2016-2021)
        6.3.2 United States Human Insulin Delivery System Revenue Market Share by Type (2016-2021)
        6.3.3 United States Human Insulin Delivery System Price by Type (2016-2021)
    6.4 United States Human Insulin Delivery System Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Human Insulin Delivery System Sales Forecast by Type (2022-2027)
        6.4.2 United States Human Insulin Delivery System Revenue Forecast by Type (2022-2027)
        6.4.3 United States Human Insulin Delivery System Price Forecast by Type (2022-2027)
    6.5 United States Human Insulin Delivery System Historic Market Review by Application (2016-2021)
        6.5.1 United States Human Insulin Delivery System Sales Market Share by Application (2016-2021)
        6.5.2 United States Human Insulin Delivery System Revenue Market Share by Application (2016-2021)
        6.5.3 United States Human Insulin Delivery System Price by Application (2016-2021)
    6.6 United States Human Insulin Delivery System Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Human Insulin Delivery System Sales Forecast by Application (2022-2027)
        6.6.2 United States Human Insulin Delivery System Revenue Forecast by Application (2022-2027)
        6.6.3 United States Human Insulin Delivery System Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Human Insulin Delivery System Market Size YoY Growth 2016-2027
    7.2 North America Human Insulin Delivery System Market Facts & Figures by Country
        7.2.1 North America Human Insulin Delivery System Sales by Country (2016-2021)
        7.2.2 North America Human Insulin Delivery System Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Human Insulin Delivery System Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Human Insulin Delivery System Market Facts & Figures by Region
        8.2.1 Asia Pacific Human Insulin Delivery System Sales by Region (2016-2021)
        8.2.2 Asia Pacific Human Insulin Delivery System Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Human Insulin Delivery System Market Size YoY Growth 2016-2027
    9.2 Europe Human Insulin Delivery System Market Facts & Figures by Country
        9.2.1 Europe Human Insulin Delivery System Sales by Country (2016-2021)
        9.2.2 Europe Human Insulin Delivery System Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Human Insulin Delivery System Market Size YoY Growth 2016-2027
    10.2 Latin America Human Insulin Delivery System Market Facts & Figures by Country
        10.2.1 Latin America Human Insulin Delivery System Sales by Country (2016-2021)
        10.2.2 Latin America Human Insulin Delivery System Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Human Insulin Delivery System Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Human Insulin Delivery System Market Facts & Figures by Country
        11.2.1 Middle East and Africa Human Insulin Delivery System Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Human Insulin Delivery System Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 BD
        12.1.1 BD Corporation Information
        12.1.2 BD Description and Business Overview
        12.1.3 BD Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 BD Human Insulin Delivery System Products Offered
        12.1.5 BD Recent Development
    12.2 Novo Nordisk
        12.2.1 Novo Nordisk Corporation Information
        12.2.2 Novo Nordisk Description and Business Overview
        12.2.3 Novo Nordisk Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Novo Nordisk Human Insulin Delivery System Products Offered
        12.2.5 Novo Nordisk Recent Development
    12.3 Medtronic
        12.3.1 Medtronic Corporation Information
        12.3.2 Medtronic Description and Business Overview
        12.3.3 Medtronic Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Medtronic Human Insulin Delivery System Products Offered
        12.3.5 Medtronic Recent Development
    12.4 Sanofi
        12.4.1 Sanofi Corporation Information
        12.4.2 Sanofi Description and Business Overview
        12.4.3 Sanofi Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Sanofi Human Insulin Delivery System Products Offered
        12.4.5 Sanofi Recent Development
    12.5 ELI Lilly and Company
        12.5.1 ELI Lilly and Company Corporation Information
        12.5.2 ELI Lilly and Company Description and Business Overview
        12.5.3 ELI Lilly and Company Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 ELI Lilly and Company Human Insulin Delivery System Products Offered
        12.5.5 ELI Lilly and Company Recent Development
    12.6 Ypsomed Holding
        12.6.1 Ypsomed Holding Corporation Information
        12.6.2 Ypsomed Holding Description and Business Overview
        12.6.3 Ypsomed Holding Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Ypsomed Holding Human Insulin Delivery System Products Offered
        12.6.5 Ypsomed Holding Recent Development
    12.7 Animas Corporation
        12.7.1 Animas Corporation Corporation Information
        12.7.2 Animas Corporation Description and Business Overview
        12.7.3 Animas Corporation Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Animas Corporation Human Insulin Delivery System Products Offered
        12.7.5 Animas Corporation Recent Development
    12.8 Tandem Diabetes Care
        12.8.1 Tandem Diabetes Care Corporation Information
        12.8.2 Tandem Diabetes Care Description and Business Overview
        12.8.3 Tandem Diabetes Care Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Tandem Diabetes Care Human Insulin Delivery System Products Offered
        12.8.5 Tandem Diabetes Care Recent Development
    12.9 Insulet Corporation
        12.9.1 Insulet Corporation Corporation Information
        12.9.2 Insulet Corporation Description and Business Overview
        12.9.3 Insulet Corporation Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Insulet Corporation Human Insulin Delivery System Products Offered
        12.9.5 Insulet Corporation Recent Development
    12.10 Biocon
        12.10.1 Biocon Corporation Information
        12.10.2 Biocon Description and Business Overview
        12.10.3 Biocon Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Biocon Human Insulin Delivery System Products Offered
        12.10.5 Biocon Recent Development
    12.11 BD
        12.11.1 BD Corporation Information
        12.11.2 BD Description and Business Overview
        12.11.3 BD Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 BD Human Insulin Delivery System Products Offered
        12.11.5 BD Recent Development
    12.12 Johnson & Johnson
        12.12.1 Johnson & Johnson Corporation Information
        12.12.2 Johnson & Johnson Description and Business Overview
        12.12.3 Johnson & Johnson Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Johnson & Johnson Products Offered
        12.12.5 Johnson & Johnson Recent Development
    12.13 Microport
        12.13.1 Microport Corporation Information
        12.13.2 Microport Description and Business Overview
        12.13.3 Microport Human Insulin Delivery System Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Microport Products Offered
        12.13.5 Microport Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Human Insulin Delivery System Industry Trends
    13.2 Human Insulin Delivery System Market Drivers
    13.3 Human Insulin Delivery System Market Challenges
    13.4 Human Insulin Delivery System Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Human Insulin Delivery System Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Human Insulin Delivery System Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Automatic
    Table 3. Major Manufacturers of Manual
    Table 4. Global Human Insulin Delivery System Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Human Insulin Delivery System Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Human Insulin Delivery System Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Human Insulin Delivery System Sales Market Share by Regions (2016-2021)
    Table 8. Global Human Insulin Delivery System Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Human Insulin Delivery System Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Human Insulin Delivery System Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Human Insulin Delivery System Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Human Insulin Delivery System Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Human Insulin Delivery System Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Human Insulin Delivery System Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Human Insulin Delivery System Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Human Insulin Delivery System Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Human Insulin Delivery System Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Human Insulin Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Human Insulin Delivery System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin Delivery System as of 2020)
    Table 20. Key Manufacturers Human Insulin Delivery System Price (2016-2021) (US$/Unit)
    Table 21. Human Insulin Delivery System Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Insulin Delivery System Product Type
    Table 23. Date of International Manufacturers Enter into Human Insulin Delivery System Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Insulin Delivery System Sales by Type (2016-2021) (K Units)
    Table 26. Global Human Insulin Delivery System Sales Share by Type (2016-2021)
    Table 27. Global Human Insulin Delivery System Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Human Insulin Delivery System Revenue Share by Type (2016-2021)
    Table 29. Human Insulin Delivery System Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 30. Global Human Insulin Delivery System Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Human Insulin Delivery System Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Human Insulin Delivery System Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Human Insulin Delivery System Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Human Insulin Delivery System Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 35. Global Human Insulin Delivery System Sales by Application (2016-2021) (K Units)
    Table 36. Global Human Insulin Delivery System Sales Share by Application (2016-2021)
    Table 37. Global Human Insulin Delivery System Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Human Insulin Delivery System Revenue Share by Application (2016-2021)
    Table 39. Human Insulin Delivery System Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 40. Global Human Insulin Delivery System Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Human Insulin Delivery System Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Human Insulin Delivery System Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Human Insulin Delivery System Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Human Insulin Delivery System Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 45. United States Human Insulin Delivery System Sales (K Units) of Key Companies (2016-2021)
    Table 46. United States Human Insulin Delivery System Sales Share by Company (2016-2021)
    Table 47. United States Human Insulin Delivery System Revenue (US$ Million) by Company (2016-2021)
    Table 48. United States Human Insulin Delivery System Revenue Share by Company (2016-2021)
    Table 49. United States Human Insulin Delivery System Sales (K Units) by Type (2016-2021)
    Table 50. United States Human Insulin Delivery System Sales Share by Type (2016-2021)
    Table 51. United States Human Insulin Delivery System Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. United States Human Insulin Delivery System Price (US$/Unit) by Type (2016-2021)
    Table 53. United States Human Insulin Delivery System Sales (K Units) by Type (2022-2027)
    Table 54. United States Human Insulin Delivery System Sales Share by Type (2022-2027)
    Table 55. United States Human Insulin Delivery System Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. United States Human Insulin Delivery System Revenue Share by Type (2022-2027)
    Table 57. United States Human Insulin Delivery System Price (US$/Unit) by Type (2022-2027)
    Table 58. United States Human Insulin Delivery System Sales (K Units) by Application (2016-2021)
    Table 59. United States Human Insulin Delivery System Sales Share by Application (2016-2021)
    Table 60. United States Human Insulin Delivery System Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. United States Human Insulin Delivery System Price (US$/Unit) by Application (2016-2021)
    Table 62. United States Human Insulin Delivery System Sales (K Units) by Application (2022-2027)
    Table 63. United States Human Insulin Delivery System Sales Share by Application (2022-2027)
    Table 64. United States Human Insulin Delivery System Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. United States Human Insulin Delivery System Revenue Share by Application (2022-2027)
    Table 66. United States Human Insulin Delivery System Price (US$/Unit) by Application (2022-2027)
    Table 67. North America Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
    Table 68. North America Human Insulin Delivery System Sales Market Share by Country (2016-2021)
    Table 69. North America Human Insulin Delivery System Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Human Insulin Delivery System Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Human Insulin Delivery System Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Human Insulin Delivery System Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Human Insulin Delivery System Revenue Market Share by Region (2016-2021)
    Table 75. Europe Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Human Insulin Delivery System Sales Market Share by Country (2016-2021)
    Table 77. Europe Human Insulin Delivery System Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Human Insulin Delivery System Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Human Insulin Delivery System Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Human Insulin Delivery System Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Human Insulin Delivery System Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Human Insulin Delivery System Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Human Insulin Delivery System Revenue Market Share by Country (2016-2021)
    Table 87. BD Corporation Information
    Table 88. BD Description and Business Overview
    Table 89. BD Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 90. BD Human Insulin Delivery System Product
    Table 91. BD Recent Development
    Table 92. Novo Nordisk Corporation Information
    Table 93. Novo Nordisk Description and Business Overview
    Table 94. Novo Nordisk Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 95. Novo Nordisk Product
    Table 96. Novo Nordisk Recent Development
    Table 97. Medtronic Corporation Information
    Table 98. Medtronic Description and Business Overview
    Table 99. Medtronic Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 100. Medtronic Product
    Table 101. Medtronic Recent Development
    Table 102. Sanofi Corporation Information
    Table 103. Sanofi Description and Business Overview
    Table 104. Sanofi Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 105. Sanofi Product
    Table 106. Sanofi Recent Development
    Table 107. ELI Lilly and Company Corporation Information
    Table 108. ELI Lilly and Company Description and Business Overview
    Table 109. ELI Lilly and Company Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 110. ELI Lilly and Company Product
    Table 111. ELI Lilly and Company Recent Development
    Table 112. Ypsomed Holding Corporation Information
    Table 113. Ypsomed Holding Description and Business Overview
    Table 114. Ypsomed Holding Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 115. Ypsomed Holding Product
    Table 116. Ypsomed Holding Recent Development
    Table 117. Animas Corporation Corporation Information
    Table 118. Animas Corporation Description and Business Overview
    Table 119. Animas Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 120. Animas Corporation Product
    Table 121. Animas Corporation Recent Development
    Table 122. Tandem Diabetes Care Corporation Information
    Table 123. Tandem Diabetes Care Description and Business Overview
    Table 124. Tandem Diabetes Care Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 125. Tandem Diabetes Care Product
    Table 126. Tandem Diabetes Care Recent Development
    Table 127. Insulet Corporation Corporation Information
    Table 128. Insulet Corporation Description and Business Overview
    Table 129. Insulet Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 130. Insulet Corporation Product
    Table 131. Insulet Corporation Recent Development
    Table 132. Biocon Corporation Information
    Table 133. Biocon Description and Business Overview
    Table 134. Biocon Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 135. Biocon Product
    Table 136. Biocon Recent Development
    Table 137. Roche Corporation Information
    Table 138. Roche Description and Business Overview
    Table 139. Roche Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 140. Roche Product
    Table 141. Roche Recent Development
    Table 142. Johnson & Johnson Corporation Information
    Table 143. Johnson & Johnson Description and Business Overview
    Table 144. Johnson & Johnson Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 145. Johnson & Johnson Product
    Table 146. Johnson & Johnson Recent Development
    Table 147. Microport Corporation Information
    Table 148. Microport Description and Business Overview
    Table 149. Microport Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 150. Microport Product
    Table 151. Microport Recent Development
    Table 152. Human Insulin Delivery System Market Trends
    Table 153. Human Insulin Delivery System Market Drivers
    Table 154. Human Insulin Delivery System Market Challenges
    Table 155. Human Insulin Delivery System Market Restraints
    Table 156. Human Insulin Delivery System Customers List
    Table 157. Human Insulin Delivery System Distributors List
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Insulin Delivery System Product Picture
    Figure 2. Global Human Insulin Delivery System Sales Market Share by Type in 2020 & 2027
    Figure 3. Automatic Product Picture
    Figure 4. Manual Product Picture
    Figure 5. Global Human Insulin Delivery System Sales Market Share by Application in 2020 & 2027
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Homecare
    Figure 9. Human Insulin Delivery System Report Years Considered
    Figure 10. Global Human Insulin Delivery System Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Human Insulin Delivery System Market Size 2016-2027 (US$ Million)
    Figure 12. Global Human Insulin Delivery System Sales 2016-2027 (K Units)
    Figure 13. Global Human Insulin Delivery System Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Human Insulin Delivery System Sales Market Share by Region (2016-2021)
    Figure 15. Global Human Insulin Delivery System Sales Market Share by Region in 2020
    Figure 16. Global Human Insulin Delivery System Revenue Market Share by Region (2016-2021)
    Figure 17. Global Human Insulin Delivery System Revenue Market Share by Region in 2020
    Figure 18. Global Human Insulin Delivery System Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Human Insulin Delivery System Revenue in 2020
    Figure 20. Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Human Insulin Delivery System Sales Market Share by Type (2016-2021)
    Figure 22. Global Human Insulin Delivery System Sales Market Share by Type in 2020
    Figure 23. Global Human Insulin Delivery System Revenue Market Share by Type (2016-2021)
    Figure 24. Global Human Insulin Delivery System Revenue Market Share by Type in 2020
    Figure 25. Global Human Insulin Delivery System Sales Market Share by Application (2016-2021)
    Figure 26. Global Human Insulin Delivery System Sales Market Share by Application in 2020
    Figure 27. Global Human Insulin Delivery System Revenue Market Share by Application (2016-2021)
    Figure 28. Global Human Insulin Delivery System Revenue Market Share by Application in 2020
    Figure 29. United States Human Insulin Delivery System Sales Growth Rate 2016-2027 (K Units)
    Figure 30. United States Human Insulin Delivery System Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. United States Human Insulin Delivery System Market Share in Global Market 2016-2027
    Figure 32. United States 5 and 10 Largest Human Insulin Delivery System Players Market Share by Revenue in Human Insulin Delivery System in 2020
    Figure 33. United States Human Insulin Delivery System Revenue Share by Type (2016-2021)
    Figure 34. United States Human Insulin Delivery System Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. United States Human Insulin Delivery System Revenue Share by Application (2016-2021)
    Figure 36. United States Human Insulin Delivery System Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Human Insulin Delivery System Sales Growth Rate 2016-2021 (K Units)
    Figure 38. North America Human Insulin Delivery System Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Human Insulin Delivery System Sales Market Share by Country in 2020
    Figure 40. North America Human Insulin Delivery System Revenue Market Share by Country in 2020
    Figure 41. U.S. Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 42. U.S. Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 44. Canada Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Human Insulin Delivery System Sales Growth Rate 2016-2021 (K Units)
    Figure 46. Europe Human Insulin Delivery System Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Human Insulin Delivery System Sales Market Share by Country in 2020
    Figure 48. Europe Human Insulin Delivery System Revenue Market Share by Country in 2020
    Figure 49. Germany Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 50. Germany Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 52. France Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 54. U.K. Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 56. Italy Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Russia Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Human Insulin Delivery System Sales Growth Rate 2016-2021 (K Units)
    Figure 60. Asia Pacific Human Insulin Delivery System Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Human Insulin Delivery System Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Human Insulin Delivery System Revenue Market Share by Region in 2020
    Figure 63. China Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 64. China Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 66. Japan Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 68. South Korea Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 70. India Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 72. Australia Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Taiwan Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 74. Taiwan Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Indonesia Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Thailand Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Malaysia Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Philippines Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 82. Philippines Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Vietnam Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 84. Vietnam Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Latin America Human Insulin Delivery System Sales Growth Rate 2016-2021 (K Units)
    Figure 86. Latin America Human Insulin Delivery System Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 87. Latin America Human Insulin Delivery System Sales Market Share by Country in 2020
    Figure 88. Latin America Human Insulin Delivery System Revenue Market Share by Country in 2020
    Figure 89. Mexico Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Mexico Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Brazil Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 92. Brazil Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Argentina Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 94. Argentina Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Middle East and Africa Human Insulin Delivery System Sales Growth Rate 2016-2021 (K Units)
    Figure 96. Middle East and Africa Human Insulin Delivery System Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 97. Middle East and Africa Human Insulin Delivery System Sales Market Share by Country in 2020
    Figure 98. Middle East and Africa Human Insulin Delivery System Revenue Market Share by Country in 2020
    Figure 99. Turkey Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 100. Turkey Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Saudi Arabia Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 102. Saudi Arabia Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. UAE Human Insulin Delivery System Sales Growth Rate (2016-2021) (K Units)
    Figure 104. UAE Human Insulin Delivery System Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. Human Insulin Delivery System Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BD
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Roche
Johnson & Johnson
Microport
Frequently Asked Questions
Human Insulin Delivery System report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Insulin Delivery System report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Insulin Delivery System report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports